Table 3.
Loop A-dependent pattern A (n = 37) | Loop A-independent pattern B (n = 10) | Area under the curve (95 % CI) | p value* | |
---|---|---|---|---|
AQP-M23 binding | 4.52 (3.57–5.48) | 6.02 (3.86–8.19) | 0.50 (0.25–0.75) | 0.999 |
AQP4-M1 binding | 1.42 (1.01–1.83) | 1.78 (0.59–2.97) | 0.56 (0.33–0.78) | 0.999 |
AQP4-M1 (% M23) | 25.1 (19.3–31.1) | 28.1 (10.0–31.5) | 0.78 (0.59–0.97) | 0.405 |
AQP4-mycA binding | 1.95 (1.69–2.21) | 5.66 (4.12–7.19) | 0.99 (0.96–1.00) | <0.001 |
AQP4-mycA (% M23) | 24.5 (18.5–30.52) | 88.6 (80.4–96.8) | 1.00 (1.00) | <0.001 |
AQP4-delA3 binding | 2.15 (1.75–2.56) | 5.42 (3.77–7.07) | 0.96 (0.90–1.00) | <0.001 |
AQP4-delA3 (% M23) | 28.7 (21.9–35.5) | 86.2 (77.0–95.4) | 0.97 (0.92–1.00) | <0.001 |
AQP4-mycC binding | 1.36 (1.32–1.41) | 1.49 (1.38–1.60) | 0.88 (0.72–1.00) | 0.045 |
AQP4-mycC (% M23) | 11.1 (7.4–14.8) | 20.6 (8.7–32.5) | 0.72 (0.52–0. 93) | 0.999 |
AQP4-N153Q binding | 3.47 (2.86–4.07) | 5.42 (3.63–7.20) | 0.75 (0.58–0.92) | 0.750 |
AQP4-N153Q (% M23) | 61.3 (49.1–73.5) | 89.6 (74.2–100) | 0.72 (0.55–0.89) | 0.999 |
AQP4-mycE binding | 1.14 (1.11–1.17) | 1.29 (1.05–1.53) | 0.63 (0.33–0.92) | 0.999 |
AQP4-mycE (% M23) | 5.8 (3.7–7.9) | 3.7 (2.0–5.5) | 0.54 (0.36–0.71) | 0.999 |
AQP4-H230G binding | 2.35 (1.80–2.89) | 3.94 (2.22–5.67) | 0.71 (0.52–0.91) | 0.999 |
AQP4-H230G (% M23) | 31.3 (25.0–38.2) | 53.6 (35.7–71.4) | 0.74 (0.59–0.90) | 0.870 |
AQP4-M23, AQP4-M1, and extracellular loop A, C, and E mutations were expressed in HEK-293A cells and assayed to categorize pattern A and pattern B serum samples as indicated in Fig. 3. Data are shown as means with 95 % confidence interval. Binding binding ratios
*The area under the curve was analyzed by receiver operator curve (ROC) analysis and p values were corrected for 15 comparisons